[Economic evaluation of monitoring systems of ketones in blood for the diagnosis and prevention of ketoacidosis]
Espin Balbino J, Garcia Mochon L, Epstein D
Record ID 32010001487
English, Spanish
Authors' recommendations:
With a probability of severe event of 24% for 6 months, a RO of 0.61 and a test execution of 0.28, the incremental cost per severe event avoided in the use of capillary ketone per is € 1.273. Drawing any conclusion about the cost-effectiveness is diffi cult since there are no data to estimate the quality of life of a patient type 1 with ketosis in Spain. If we consider that the health service might be willing to pay € 30,000 per additional healthylife year, and that a serious adverse event results in up to one week with very low quality of life, then the health service might be willing to pay up to € 577 for each event avoided. Under these assumptions, blood ketone tests would not be cost-effective for the base case. Blood ketone testing might be cost-effective under alternative scenarios, for instance in patients with a higher expected prevalence of severe events, or if a blood test strip cost less than € 1.5. These results indicate that determining the presence of ketonic bodies by capillary blood ketone testing is not cost-effective with patients having a good control of glucose and a low risk of ketosis. However, costeffectiveness may be greater in patients at a high risk or if the blood strip cost was lower. Moreover, the results are very sensitive to the frequency of ketonic body determination and the odds ratio of a severe event with capillary blood ketone testing versus urine testing.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
https://www.aetsa.org/download/publicaciones/antiguas/AETSA_2007-14_Cetonicos.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Spain
MeSH Terms
- Blood Glucose Self-Monitoring
- Cost-Benefit Analysis
- Ketones
- Monitoring, Physiologic
- Diabetic Ketoacidosis
Contact
Organisation Name:
Andalusian Health Technology Assessment Area
Contact Address:
Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name:
aetsa.csalud@juntadeandalucia.es
Contact Email:
aetsa.csalud@juntadeandalucia.es
Copyright:
Andalusian Agency for Health Technology Assessment (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.